Rosetta Omics
Rosetta Omics is focused on precision medicine in oncology, utilizing high-resolution mass spectrometry profiling and AI to characterize tumors. Their innovative approach integrates seamlessly into standard clinical procedures, enabling oncologists and clinicians to make informed treatment decisions based on comprehensive molecular profiling. By identifying biomarkers and utilizing machine learning algorithms, they enhance the prediction of treatment responses, ultimately improving patient outcomes and reducing costs associated with ineffective therapies. Their technology stands out by analyzing thousands of proteins and analytes from minimal biopsy material, positioning them as a leader in the precision medicine market.
Rosetta Omics
Rosetta Omics is focused on precision medicine in oncology, utilizing high-resolution mass spectrometry profiling and AI to characterize tumors. Their innovative approach integrates seamlessly into standard clinical procedures, enabling oncologists and clinicians to make informed treatment decisions based on comprehensive molecular profiling. By identifying biomarkers and utilizing machine learning algorithms, they enhance the prediction of treatment responses, ultimately improving patient outcomes and reducing costs associated with ineffective therapies. Their technology stands out by analyzing thousands of proteins and analytes from minimal biopsy material, positioning them as a leader in the precision medicine market.